Composition
- Active ingredients
- PRUCALOPRIDE SUCCINATE EQ 2MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- PRUCALOPRIDE SUCCINATE EQ 2MG BASE · TabletThis page
- PRUCALOPRIDE SUCCINATE EQ 1MG BASE · TabletNDA210166-001 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA210166.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Motegrity
- Active substance
- prucalopride succinate
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Takeda Pharms USA
- Status
- Prescription
- FDA approval
- 14 Dec 2018
- Application
- NDA210166-002